All Insights
Telemedicine on the rise in Europe
The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment
CJEU clarifies conditions for obtaining SPC protection for medicinal products
Royalty Pharma: the CJEU's latest decision on Supplementary Protection Certificates addresses when medicinal products can be "protected by a basic
Proposal to amend the Good Governance Code of Listed Companies
The Spanish National Securities Market Commission (the "CNMV") is expected to approve, at the end of the first semester of
Coronavirus Legal Briefing | The latest on the UK government's funding schemes for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus Legal Briefing | The EU's exit strategy for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
State aid | Part III – European Commission amends Temporary Framework to include aid for Life Sciences sector
Life sciences businesses working on Covid-19 related products may be able to benefit from government funding for a range of
Diversifying into Covid-19 protection products : relaxation of the regulatory regime
In light of the impact of Covid-19 on businesses and the critical need for additional supplies for frontline staff and
Coronavirus Legal Briefing | What we're seeing
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus A guide for your business
COVID-19 – and the measures governments have implemented to slow the spread of the virus – represent an unprecedented challenge
